zinc
ion
involv
mani
differ
cellular
process
proven
crucial
proper
fold
activ
variou
cellular
enzym
transcript
factor
probabl
import
cofactor
numer
viral
protein
well
nevertheless
intracellular
concentr
free
maintain
rel
low
level
metallothionein
like
due
fact
serv
intracellular
second
messeng
may
trigger
apoptosi
decreas
protein
synthesi
elev
concentr
interestingli
cell
cultur
studi
high
concentr
addit
compound
stimul
cellular
import
hinokitol
hk
pyrrolidin
dithiocarbam
pdtc
pyrithion
pt
found
inhibit
replic
variou
rna
virus
includ
influenza
viru
respiratori
syncyti
viru
sever
picornavirus
although
previou
studi
provid
limit
mechanist
inform
suggest
intracellular
level
affect
common
step
replic
cycl
virus
cell
cultur
pt
stimul
uptak
within
minut
inhibit
rna
viru
replic
mechan
studi
reason
detail
picornavirus
vitro
studi
purifi
rhinoviru
polioviru
proteas
reveal
proteas
activ
inhibit
line
inhibit
polyprotein
process
zinc
ion
observ
cell
infect
human
rhinoviru
coxsackieviru
replic
segment
negativestrand
rna
virus
influenza
viru
howev
depend
polyprotein
process
effect
pdtcmediat
import
therefor
hypothes
result
inhibit
viral
rnadepend
rna
polymeras
rdrp
cellular
cofactor
moreov
inhibitori
effect
activ
purifi
rdrp
rhinovirus
hepat
c
viru
note
investig
detail
detail
effect
zinc
ion
current
larg
unknown
nidovirus
larg
group
positivestrand
rna
rna
virus
includ
major
pathogen
human
livestock
sever
acut
respiratori
syndrom
coronaviru
sarscov
human
coronavirus
arterivirus
equin
arter
viru
eav
porcin
reproduct
respiratori
syndrom
viru
prrsv
common
ancestri
nidovirus
reflect
similar
genom
organ
express
strategi
conserv
number
key
enzymat
function
larg
replicas
polyprotein
hallmark
corona
arteriviru
replic
cycl
transcript
nest
set
subgenom
sg
mrna
viral
structur
accessori
protein
gene
express
analog
picornavirus
zinc
ion
demonstr
inhibit
certain
proteolyt
cleavag
process
coronaviru
replicas
polyprotein
infect
cell
cellfre
system
studi
report
zincionophor
pyrithion
pt
combin
potent
inhibitor
replic
sarscoronaviru
sarscov
equin
arter
viru
eav
cell
cultur
assess
whether
besid
possibl
effect
proteolyt
process
nidoviru
rtc
subunit
rna
synthesi
directli
affect
employ
vitro
system
sarscov
eav
rna
synthesi
base
membraneassoci
rtc
isol
infect
cell
refer
rtc
assay
addit
use
vitro
recombin
rdrp
assay
directli
studi
effect
zinc
ion
rdrp
sarscov
eav
use
independ
vitro
approach
abl
demonstr
directli
impair
nidoviru
rna
synthesi
sinc
strong
inhibitori
effect
rtc
rdrp
assay
interestingli
inhibit
could
revers
addit
chelat
mgedta
therefor
appli
compound
stop
restart
vitro
rnasynthes
activ
conveni
tool
allow
us
studi
variou
mechanist
aspect
arteri
coronaviru
rna
synthesi
detail
addit
zincmedi
inhibit
nidoviru
rna
synthesi
describ
may
provid
interest
basi
explor
use
zincionophor
antivir
therapi
zinc
ion
involv
mani
differ
cellular
process
concentr
free
maintain
rel
low
level
metallothionein
compound
stimul
import
cell
pt
previous
found
inhibit
replic
sever
picornavirus
includ
rhinovirus
footandmouth
diseas
viru
coxsackieviru
mengoviru
cell
cultur
determin
whether
similar
effect
nidovirus
investig
effect
pt
replic
eav
sarscov
cell
use
report
virus
express
green
fluoresc
protein
gfp
ie
eavgfp
sarscovgfp
eavgfp
encod
ntermin
fusion
gfp
viral
nonstructur
protein
one
cleavag
product
replicas
polyprotein
thu
provid
direct
readout
translat
replicas
gene
sarscovgfp
report
express
occur
sg
mrna
follow
replac
two
accessori
proteincod
gene
orf
dispens
replic
cell
cultur
first
assess
cytotox
rang
pt
concentr
presenc
treatment
pt
concentr
combin
reduc
viabil
mockinfect
cell
h
fig
measur
colorimetr
mt
viabil
assay
elev
concentr
known
inhibit
cellular
translat
also
use
metabol
label
assess
effect
pt
cellular
protein
synthesi
incub
cell
h
combin
pt
mention
follow
metabol
label
reveal
chang
overal
cellular
protein
synthesi
concentr
data
shown
use
noncytotox
condit
subsequ
test
effect
pt
eavgfp
sarscovgfp
replic
end
cell
plate
infect
multipl
infect
moi
one
hour
post
infect
h
pi
pt
ad
cultur
medium
h
pi
time
point
gfp
express
untreat
infect
cell
reach
maximum
virus
cell
fix
gfp
fluoresc
quantifi
report
gene
express
sarscovgfp
eavgfp
alreadi
significantli
inhibit
dosedepend
manner
addit
pt
alon
fig
c
effect
significantli
enhanc
ad
medium
found
addit
alon
also
reduc
viru
replic
level
close
cytotox
concentr
cell
data
shown
like
due
poor
solubl
phosphatecontain
medium
ineffici
uptak
cell
absenc
zincionophor
combin
pt
result
reduct
gfp
signal
eavgfp
sarscovgfp
respect
cytotox
observ
combin
pt
concentr
doserespons
curv
fig
valu
calcul
pt
presenc
zinc
half
maxim
inhibitori
concentr
select
indic
calcul
sarscov
eav
respect
previous
develop
assay
studi
vitro
rnasynthes
activ
rtc
isol
cell
infect
sarscov
eav
rtc
assay
cmp
incorpor
genom
replic
sg
mrna
transcript
fig
allow
us
monitor
synthesi
viral
rna
molecul
detect
hybrid
rna
nidovirusinfect
cell
benefit
assay
activ
depend
continu
protein
synthesi
allow
us
studi
viral
rna
synthesi
independ
aspect
viral
replic
cycl
investig
whether
inhibitori
effect
pt
zinc
ion
nidoviru
replic
cell
cultur
reflect
direct
effect
viral
rna
synthesi
test
effect
addit
rtc
activ
eav
fig
sarscov
fig
dosedepend
decreas
amount
rna
synthes
observ
present
virus
reduct
overal
rnasynthesi
observ
concentr
less
activ
remain
concentr
genom
synthesi
sg
mrna
product
equal
affect
test
whether
inhibit
rtc
activ
revers
rtc
reaction
start
presenc
absenc
min
reaction
split
two
aliquot
magnesiumsatur
edta
mgedta
ad
one
tube
final
concentr
mm
fig
use
mgedta
chelat
vitro
assay
specif
chelat
releas
due
higher
stabil
constant
znedta
complex
uncomplex
edta
inhibit
rtc
activ
reaction
data
shown
like
chelat
crucial
rdrp
activ
wherea
mgedta
effect
control
reaction
without
fig
compar
lane
shown
fig
eav
rtc
activ
inhibit
fig
c
lane
could
restor
addit
mgedta
fig
lane
level
observ
control
reaction
without
fig
lane
compar
untreat
control
eav
rtc
assay
produc
approxim
less
rna
consist
shorter
reaction
time
addit
mgedta
versu
min
lane
respect
surprisingli
sarscov
rtc
assay
consecut
supplement
mgedta
incorpor
slightli
cmp
compar
untreat
control
reaction
fig
compar
lane
effect
due
chelat
alreadi
present
postnuclear
supernat
pn
sarscovinfect
cell
increas
observ
mgedta
ad
control
reaction
without
addit
fig
lane
establish
whether
inhibit
rtc
activ
might
due
direct
effect
nidoviru
rdrp
activ
test
effect
activ
purifi
recombin
rdrp
sarscov
eav
use
previous
develop
rdrp
assay
use
polyu
templat
eav
rdrp
incorpor
amp
rna
product
nt
length
fig
initi
de
novo
line
previou
observ
presenc
conserv
prime
loop
sequenc
unlik
eav
rdrp
vitro
activ
sarscov
rdrp
lack
prime
loop
shown
strictli
primerdepend
thu
studi
rdrp
activ
sarscov
prime
polyu
templat
use
fig
therebi
allow
us
sampl
amp
incorpor
describ
previous
specif
control
use
previous
describ
sarscov
mutant
contain
aspart
alanin
substitut
motif
rdrp
activ
site
eav
engin
aspart
alanin
substitut
correspond
site
eav
mutant
rdrp
show
greatli
reduc
amp
incorpor
assay
fig
confirm
radiolabel
rna
product
deriv
nidoviru
rdrp
activ
addit
rdrp
assay
result
strong
dosedepend
inhibit
enzymat
activ
eav
sarscov
enzym
fig
b
respect
similar
observ
rtc
assay
fact
compar
dival
metal
ion
typic
bind
amino
acid
side
chain
contain
oxygen
atom
rather
sulfur
group
effici
inhibitor
sarscov
rdrp
activ
supplement
fig
test
whether
rtc
assay
rdrp
inhibit
zinc
ion
revers
rdrp
assay
preincub
mm
concentr
consist
gave
inhibit
min
mm
mgedta
ad
control
reaction
reaction
inhibit
sampl
incub
anoth
min
fig
shown
fig
inhibit
eav
rdrp
activ
could
revers
chelat
fig
compar
lane
amount
product
synthes
consist
synthes
control
reaction
fig
compar
lane
within
expect
rang
given
shorter
reaction
time
inhibit
sarscov
rdrp
revers
well
incub
addit
mgedta
sarscov
incorpor
label
incorpor
standard
reaction
fig
slightli
lower
expect
yield
may
caus
elev
concentr
shown
suboptim
activ
result
releas
mgedta
upon
chelat
eav
close
inspect
rdrp
assay
reveal
less
pronounc
effect
gener
fulllength
product
synthesi
smaller
reaction
intermedi
fig
suggest
specif
inhibit
initi
step
eav
rna
synthesi
test
hypothesi
rtc
assay
incub
min
unlabel
ctp
initi
reaction
split
two
ctp
ad
tube
puls
ad
one
tube
sampl
taken
differ
time
point
reaction
fig
fig
show
presenc
cmp
predominantli
incorpor
nascent
rna
molecul
alreadi
past
initi
phase
moment
ad
reaction
new
initi
occur
indic
smear
short
radiolabel
product
progress
shift
toward
posit
fulllength
genom
rna
suggest
affect
elong
phase
eav
rna
synthesi
specif
inhibit
initi
also
explain
rel
weak
signal
intens
smaller
sg
mrna
band
eg
compar
rel
chang
signal
produc
presenc
sinc
multipl
initi
event
requir
short
molecul
obtain
signal
intens
similar
result
singl
initi
event
long
genom
rna
eg
time
case
contrast
eav
effect
rna
synthesi
sarscov
rtc
limit
initi
appear
impair
elong
phase
well
given
addit
complet
block
incorpor
cmp
ad
min
start
reaction
fig
rdrp
assay
short
templat
use
made
technic
imposs
experi
similar
perform
complet
rtc
howev
previous
notic
low
concentr
atp
sarscov
rdrp
activ
restrict
addit
singl
nucleotid
primer
eav
mainli
produc
short
nt
long
abort
rna
product
fraction
full
length
product
common
de
novo
initi
rdrp
allow
us
separ
studi
effect
initi
elong
perform
experi
puls
low
concentr
atp
follow
chase
presenc
unlabel
atp
increas
process
allow
us
studi
elong
fig
c
describ
previous
result
experi
agreement
obtain
isol
rtc
eav
initi
dinucleotid
synthesi
complet
inhibit
presenc
mm
supplement
fig
amount
reaction
intermedi
shorter
nt
diminish
time
product
templat
rdrp
alreadi
initi
elong
fulllength
molecul
fig
right
panel
consist
observ
eav
rdrp
remain
capabl
extend
synthet
dinucleotid
apa
trinucleotid
presenc
supplement
fig
like
due
absenc
reiniti
reaction
shown
fig
low
process
eav
rdrp
substrat
competit
remain
atp
fold
excess
unlabel
atp
differ
time
point
small
absenc
rdrp
continu
initi
indic
ladder
smallers
rna
molecul
fulllength
product
fig
left
panel
time
cours
shown
supplement
fig
contrast
addit
sarscov
rdrp
reaction
also
block
elong
sinc
extens
radiolabel
primer
observ
absenc
fig
left
panel
longer
occur
fig
right
panel
assess
whether
affect
interact
recombin
sarscov
templat
use
assay
perform
electromobl
shift
assay
emsa
presenc
absenc
fig
measur
bind
affin
rdrp
templat
determin
fraction
bound
templat
variou
protein
concentr
observ
fold
reduct
rna
bind
present
assay
fig
also
assess
whether
preincub
rdrp
rna
requir
drop
bind
affin
found
signific
differ
experi
involv
preincub
data
shown
bind
observ
similar
rna
bind
assay
perform
purifi
eav
rdrp
likewis
bind
rna
pulldown
experi
talonbead
radiolabel
eav
genom
rna
variou
short
rna
templat
includ
polyu
wherea
abl
detect
bind
control
protein
sarscov
demonstr
rna
dna
bind
activ
use
assay
present
remain
unclear
abl
detect
bind
recombin
eav
rna
templat
although
varieti
compound
studi
regist
antivir
current
still
lack
effect
treatment
sar
nidovirusrel
diseas
rdrp
suitabl
target
antivir
drug
develop
activ
strictli
virusspecif
may
block
without
sever
affect
key
cellular
function
sever
inhibitor
develop
polymeras
eg
human
immunodefici
viru
hiv
hepat
c
viru
current
use
antivir
therapi
clinic
trial
therefor
advanc
molecular
knowledg
nidoviru
rdrp
larger
enzym
complex
part
util
potenti
recent
develop
vitro
rdrp
assay
could
ultim
aid
develop
effect
antivir
strategi
zinc
ion
zincionophor
pt
pdtc
previous
describ
potent
inhibitor
variou
rna
virus
therefor
investig
whether
ptstimul
import
zinc
ion
cell
also
inhibit
replic
nidovirus
cell
cultur
use
gfpexpress
eav
sarscov
found
combin
pt
effici
inhibit
replic
caus
detect
cytox
fig
inhibit
replic
pt
similar
concentr
previous
observ
sever
picornavirus
rhinovirus
footandmouth
diseas
viru
coxsackieviru
mengoviru
inhibitori
effect
replic
picornavirus
appear
due
interfer
viral
polyprotein
process
infect
coronaviru
mous
hepat
viru
mhv
also
interf
replicas
polyprotein
cleavag
albeit
much
higher
concentr
use
studi
sinc
impair
replicas
process
indirectli
affect
viral
rna
synthesi
infect
cell
use
two
recent
develop
vitro
assay
investig
whether
also
affect
nidoviru
rna
synthesi
directli
vitro
studi
reveal
strong
inhibitori
effect
zinc
ion
rnasynthes
activ
isol
eav
sarscov
rtc
assay
recombin
enzym
subsequ
demonstr
like
due
direct
inhibit
rdrp
function
inhibitori
effect
could
revers
chelat
zinc
ion
provid
interest
experiment
onoff
approach
studi
nidoviru
rna
synthesi
addit
follow
initi
eav
rna
synthesi
littl
effect
ntp
incorpor
molecul
whose
synthesi
alreadi
initi
absenc
fig
indic
affect
elong
increas
termin
frequenc
previous
found
therefor
appear
specif
inhibitor
initi
phase
eav
rna
synthesi
contrast
inhibit
sarscov
rdrp
activ
also
elong
phase
rna
synthesi
probabl
directli
affect
templat
bind
fig
coronavirus
zinc
ion
thu
appear
inhibit
proper
proteolyt
process
replicas
polyprotein
rdrp
activ
studi
contrari
rtc
assay
millimolar
instead
micromolar
concentr
requir
nearli
complet
inhibit
nucleotid
incorpor
rdrp
assay
well
establish
dna
rna
polymeras
use
triad
conserv
aspart
residu
motif
c
bind
dival
metal
ion
like
subsequ
coordin
incom
nucleotid
polymer
reaction
also
dival
metal
ion
requir
vitro
activ
isol
sarscov
eav
rtc
recombin
rdrp
although
de
novo
initi
eav
primarili
could
substitut
cofactor
incap
support
polymeras
activ
nidoviru
rtc
rdrp
absenc
data
shown
also
report
polioviru
rdrp
moreov
inhibit
nidoviru
rdrp
activ
even
observ
low
concentr
presenc
excess
suggest
either
affin
activ
site
much
higher
compet
bind
anoth
zinc
specif
bind
site
protein
specif
protein
domain
pocket
contain
zinc
ion
may
involv
proteinprotein
interact
proteinrnadna
interact
conform
chang
enzym
structur
zincbind
domain
commonli
consist
least
three
conserv
cystein
andor
histidin
residu
within
stretch
amino
acid
zincfing
motif
metalloproteas
howev
rdrp
preced
presenc
zincbind
pocket
identifi
crystal
structur
dengu
rdrp
sequenc
analysi
eav
amino
acid
sequenc
reveal
lack
patch
rich
conserv
cystein
andor
histidin
contrast
inspect
sarscov
amino
acid
sequenc
reveal
two
patch
name
crystal
structur
present
unavail
predict
structur
repres
ctermin
twothird
enzym
publish
interestingli
model
spatial
arrang
resembl
coordin
residu
zincbind
pocket
found
motif
e
dengu
viru
rdrp
see
supplement
fig
clearli
indepth
analysi
nidoviru
rdrp
eg
structur
analysi
subsequ
mutat
studi
target
aforement
cystein
histidin
requir
provid
insight
structur
basi
inhibitori
effect
rdrp
activ
document
studi
studi
may
howev
complic
bind
prove
transient
natur
detect
current
avail
method
summari
combin
zinc
ion
zincionophor
pt
effici
inhibit
nidoviru
replic
cell
cultur
provid
interest
basi
studi
use
zincionophor
antivir
compound
although
system
effect
consid
watersolubl
zincionophor
may
better
suit
given
appar
lack
system
toxic
compound
concentr
effect
tumor
mous
xenograft
model
vitro
revers
inhibit
rdrp
also
provid
us
conveni
research
tool
gain
insight
molecular
detail
nido
viral
rna
synthesi
reveal
novel
mechanist
differ
rdrp
sarscov
eav
cell
cultur
infect
sarscov
strain
access
nr
sarscovgfp
describ
previous
procedur
involv
live
sarscov
perform
biosafeti
level
facil
leiden
univers
medic
center
cell
cultur
infect
eav
bucyru
strain
access
nr
eavgfp
describ
elsewher
one
day
prior
infect
cell
seed
transpar
black
low
fluoresc
cluster
cell
per
well
next
day
cell
infect
sarscovgfp
eavgfp
moi
h
pi
inoculum
remov
medium
contain
fetal
calf
serum
fc
ad
well
experi
pyrithion
sigma
ad
addit
infect
cell
fix
h
pi
aspir
medium
ad
paraformaldehyd
pb
wash
pb
gfp
express
quantifi
measur
fluoresc
mithra
plate
reader
berthold
nm
determin
toxic
pt
cell
expos
pt
h
incub
cell
viabil
determin
cell
titer
aq
mt
assay
promega
valu
calcul
graphpad
prism
use
nonlinear
regress
model
rna
oligonucleotid
poli
u
purchas
eurogentec
purifi
page
gel
desalt
column
ge
healthcar
anneal
rna
duplex
oligonucleotid
mix
equimolar
ratio
anneal
buffer
mm
trishcl
ph
mm
nacl
mm
edta
denatur
heat
allow
slowli
cool
room
temperatur
purifi
nondenatur
page
gel
sarscov
eav
rtc
isol
infect
cell
assay
activ
vitro
describ
previous
assess
effect
stock
solut
ad
standard
reaction
result
final
concentr
chelat
cours
reaction
magnesiumsatur
edta
mgedta
ad
final
concentr
mm
rna
isol
reaction
product
separ
denatur
sarscov
eav
agaros
formaldehyd
gel
incorpor
cmp
viral
rna
quantifi
phosphorimag
dri
gel
use
typhoon
scanner
ge
healthcar
imagequ
tl
softwar
ge
healthcar
sarscov
eav
purifi
essenti
describ
elsewher
modif
short
e
coli
plasmid
grown
autoinduct
medium
hour
hour
lysi
buffer
mm
hepe
ph
mm
nacl
mm
imidazol
supernat
appli
histrap
column
ge
healthcar
elut
perform
gradient
mm
imidazol
buffer
fraction
purifi
gel
filtrat
mm
hepe
mm
nacl
superdex
column
ge
healthcar
fraction
contain
pool
dialyz
volum
buffer
b
mm
hepe
mm
nacl
mm
dtt
glycerol
store
rdrp
sarscov
eav
mutat
obtain
sitedirect
mutagenesi
wildtyp
wt
plasmid
oligonucleotid
plasmid
oligonucleotid
describ
elsewher
mutant
protein
purifi
parallel
wt
enzym
standard
reaction
condit
rdrp
assay
purifi
sarscov
describ
elsewher
studi
effect
assay
dilut
seri
mm
ad
reaction
mixtur
yield
final
concentr
mm
eav
rdrp
assay
contain
rna
templat
poli
u
atp
perkinelm
atp
mm
trishcl
ph
mm
nacl
mm
kcl
mm
mm
glycerol
mm
dtt
unit
rnaseout
ad
reaction
give
final
concentr
mm
chelat
reaction
mgedta
ad
final
concentr
mm
reaction
termin
hour
analyz
describ
sarscov
rdrp
incub
nm
rna
duplex
minut
either
presenc
absenc
mm
reaction
analyz
describ
previous
